StockSelector.com
  Research, Select, & Monitor Saturday, May 30, 2020 7:12:12 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Immunomedics, Inc.$33.59$.29.87%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Immunomedics, Inc. has an overall rank of 7201 out of 7467 stocks based on 8 positive rankings and 10 negative rankings.

Positive Rankings
Estimated Revenue Growth
Immunomedics rank is 3
Highest Cash Growth
Immunomedics rank is 47
90 Day Gain
Immunomedics rank is 193
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, Immunomedics is ranked 460.
Target Prices
The average analysts' target price is $39.00 for Immunomedics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Immunomedics is ranked 584.
Low Put/Call
Immunomedics has a low Put/Call ratio of 0.33 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Immunomedics is ranked 941.
Up EPS Surprise
Immunomedics beat the consensus earnings estimate when it last reported quarterly earnings.
10 Day Gain
Immunomedics rank is 4101
Negative Rankings
Price-to-Sales
Immunomedics rank is 0
Negative Net Margin
Immunomedics rank is 7
Negative Revenue Growth
Immunomedics rank is 30
Price-to-Book
Immunomedics rank is 153
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Immunomedics is ranked 230.
Negative ROE
Immunomedics rank is 273
Overbought RSI
The 14 Day Relative-Strength Index for Immunomedics is 72.7. An RSI above 70 indicates the stock is overbought. Among companies with a high RSI, Immunomedics is ranked 281.
Negative ROA
Immunomedics rank is 484
High vPut/Call
Immunomedics has a high Put/Call ratio of 1.32 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Immunomedics is ranked 959.
Debt-to-Equity
Immunomedics rank is 2112







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.